Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell Carcinoma

Vitaly Margulis, Surena F. Matin, Nizar Tannir, Pheroze Tamboli, Yu Shen, Marisa Lozano, David A. Swanson, Eric Jonasch, Christopher G. Wood

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences